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Aim: This paper aims to compare the mechanical performance of metallic (Xience) and 
bioresorbable polymeric (Elixir) stents during the process of crimping and deployment. 
Methods: Finite element software ABAQUS was used to create the geometrical models and 
meshes for the balloon, stent and diseased artery. To simulate the crimping of stents, 12 rigid 
plates were generated around the stent and subjected to radially enforced displacement. The 
deployment of both stents was simulated by applying internal pressure to the balloon, where 
hard contacts were defined between balloon, stent and diseased artery. Results: Elixir stent 
exhibited a lower expansion rate than Xience stent during deployment. The stent diameter 
achieved after balloon deflation was found smaller for Elixir stent due to higher recoiling. 
Lower level of stresses was found in the plaque and artery when expanded by Elixir stent. 
Reduced expansion, increased dogboning and decreased vessel stresses were obtained when 
considering the crimping-generated residual stresses in the simulations. Conclusion: There 
is a challenge for polymeric stents to match the mechanical performance of metallic stents. 
However, polymeric stents impose lower stresses to the artery system due to less property 
mismatch between polymers and arterial tissues, which could be clinically beneficial.
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INTRODUCTION
Over the past three decades, significant improvements 
have been made in stent designs and materials, 
especially the development of drug-eluting stents 
(DESs, approved by Food and Drug Administration 
(FDA) of USA in 2002). The vast majority of DESs 
used so far have non-degradable polymer coatings, 
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incorporated with anti-proliferative drugs, to overcome 
the notorious in-stent restenosis (ISR) that represented 
an undesired drawback of bare metal stents.[1] 
Although ISR rates can be substantially reduced by 
DESs (lowered by 74% in high-risk patients), the life-
long presence of metallic alloy stents, under loads and 
corrosive conditions, could increase the risk of strut 
fracture and failure with time. This may lead to possible 
complications such as delayed healing, lethal migration 
and unstable angina.[2,3] Bioresorbable stents provide 
the advance of overcoming these possible long-
term complications of metallic stents. Biodegradable 
polymers are the most promising materials investigated 
to date.[4-6] Fully expandable polymeric biodegradable 
stents initially support the vessel wall as scaffolds with 
sufficient radial strength to prevent mechanic recoil after 
implantation. In about 6 months, arterial remodelling 
enters a stable phase, and no substantial scaffolding 
is required. Consequently, it is desirable for stents to 
dissolve after 6 months in the body, leaving behind an 
intact vessel with no pro-inflammatory substances or 
obstacles for future treatments.[7] During the process, 
the polymers gradually soften, which allows for a 
smooth disappearance of high stresses, imposed 
by the permanent stents, in the recovering artery. It 
should be noted that recent reports have suggested an 
independent relationship between bioresorbable stents 
and stent thrombosis.[8] Instead, the higher incidence 
rates of stent thrombosis were associated with the 2.5 
mm platforms.[9]
One of the major concerns for polymeric BRSs 
is their mechanical performance, especially their 
interaction with blood vessels during and after 
deployment. Agrawal et al.[10] carried out the earliest 
work in assessing the in vitro performance of the 
Duke biodegradable stents made of Poly-L lactide 
(PLLA) fibres. Results showed that a successful 
biodegradable stent could be achieved by carefully 
balancing the mechanical properties of PLLA fibres 
and geometrical design of stents. Nuutinen et al.[11] 
conducted in vitro tests of a woven fibre polymeric 
braided stent subjected to radial compression. The 
performance of such stents was not as good as metal 
ones, and the collapse pressure was found lower, even 
for thicker PLLA fibres. Bünger et al.[12] compared the 
in vivo performance of stents made of biodegradable 
PLLA and stainless steel, by monitoring the stents after 
the implantation in carotid arteries of living pigs. Both 
stents achieved initial technical success. However, 
PLLA was reported to be significantly softer than 
metallic alloys, which affected the radial stiffness of the 
implanted stents and needed to be further investigated. 
Over the last two decades, great effort has been made 
for the development of bioresorbable stents, and there 
have been many devices available in preclinical and 
clinical evaluations. Elixir DESolve (Elixir Medical 
Corporation, USA) stent, made of PLLA, is one of 
the major biodegradable stents currently available 
on the market. The polymer stents showed sufficient 
radial strength within 6 months of implantation, with 
the occurrence of bioresorption between one and two 
years.[13]
Finite element (FE) analyses have been largely used 
in modelling of stent expansion and deformation 
during the deployment process.[14-16] However, majority 
FE analyses were performed on metallic stents. For 
example, Imani et al.[17] modelled the effects of design 
on vessel wall stresses for Palmaz-Schatz, Xience 
V and NIR stents. The comparative study confirmed 
that Palmaz-Schatz stent generated 15.6% and 7.6% 
higher stresses in the arterial wall than Xience V stent 
and NIR stent, respectively. The results suggested a 
direct correlation between vessel wall stresses and 
in-stent restenosis rate, as Palmaz-Schatz stent gave 
the highest restenosis rate in clinical trials. Recent FE 
simulations on metallic stents by Schiavone et al.[18] 
also confirmed that stent design is a major factor that 
controls the expansion of the device and also the 
stresses generated in the artery. In addition, shape 
optimization of metallic stents, in terms of improved 
fatigue resistance and radial flexibility, can also be 
achieved by FE modelling.[19] On the contrary, there is 
very limited work dedicated to modelling the deformation 
of bioresorbable polymer stents, particularly during the 
process of deployment in diseased arteries.
In this paper, FE modelling was carried out to simulate 
the deployment of Elixir polymer stent in a diseased 
artery, with head-to-head comparison against Xience 
metallic stent. Particularly, the simulations considered 
the crimping step, which is necessary to fix the as-
produced stent to the catheter. The mechanical 
performance of the two stents has been compared 
directly, in terms of radial expansion and stresses in 
the stent-vessel system. In addition, results were also 
compared with those obtained without considering the 
residual stresses generated from the crimping process.
METHODS
Models for stents, balloon and artery
Geometries for Xience and Elixir stents were built using 
the NX design software. Both stents were created in 
expanded shape, with a diameter of 3 mm and a length 
of 10 mm. The geometries of both stents were based 
on dimensions found in open resource. The strut 
thickness is 80 µm and 150 µm for Xience stent and 
Elixir stent, respectively. The FE mesh contains eight-
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node incompatible brick elements, with full integration 
(C3D8I). The incompatible mode is chosen for the 
purpose of modelling large bending deformation during 
stent crimping and subsequent expansion. There are 
4-layer elements through the width and the thickness 
of all struts. The geometrical designs and FE meshes 
for both stents are given in Figure 1.
The balloon used to inflate the stents had a tri-folded 
geometry which was produced using the NX software. 
The diameter of the fully folded part is 1.25 mm and 
the total length of the balloon is 14 mm. To create the 
pattern, the tri-folded cross section was sketched first, 
and subsequently extruded for a length of 12 mm. 
Towards the ends, the balloon smoothly transits into 
a circle, 0.75 mm in diameter, over a length of 1 mm. 
This was done by using the sweeping tools in NX. The 
balloon was totally constrained at both ends as they 
are fixed to a catheter. The diameter of the expanded 
balloon was set to be 3 mm, matching the targeted 
stent or vessel diameter after deployment. Four-node 
shell elements, with reduced integration (S4R), were 
adopted to mesh the tri-folded balloon.
The diseased artery has a total length of 40 mm and a 
lumen diameter of 3 mm for the heathy part. The middle 
portion of the artery is covered by 10 mm plaque. The 
stenosis, defined as the ratio of plaque thickness to 
healthy lumen radius, was chosen to be 50%. The 
artery comprises three individual tissue layers, and the 
wall thickness is 0.27 mm, 0.35 mm and 0.38 mm for 
the intima, media and adventitia layers, respectively. 
Eight-node brick elements with reduced integration 
(C3D8R) were used to mesh the artery and the plaque. 
Four layers of elements were assigned through the 
wall of each tissue layer and eight layers of elements 
were assigned through the plaque thickness.
Geometry and mesh of the balloon-artery assembly are 
shown in Figure 2. Mesh-sensitivity studies confirmed 
the convergence of numerical results, with regards to 
stent expansion, stent recoiling and stresses in the 
stent-artery system, for the mesh adopted in this work.
Material model
Both stents were modelled as elastic-plastic, with non-
linear strain hardening [Figure 3]. The tensile stress-
strain curves for Co-Cr L605 and PLLA were taken 
from literature.[20,21] It can be noted that PLLA is much 
weaker than Co-Cr L605. Table 1 gives the essential 
properties for both materials as obtained from the 
tensile curves. Strain hardening was realised in 
ABAQUS by stating the yield stress as a function of the 
plastic strain, as also obtained from the tensile curves. 
The plaque was assumed to be hypocellular, and its 
behaviour was described by the Ogden hyperelastic 
model. The hyperelastic model parameters were 
provided in Zahedmanesh and Lally.[22] The tri-folded 
balloon was treated as a linear elastic material. The 
material density, Young’s modulus and Poisson’s ratio 
were taken as 1.1 × 106 kg/mm3, 900 MPa and 0.3, 
respectively.[23]
It is well recognised that the arterial layers possess 
distinct anisotropic behaviour as they are reinforced by 
two families of collagen fibres. Here, the established 
Holzapfel-Gasser-Ogden (HGO) anisotropic hyperelastic 
model[24] was employed to describe the anisotropic 
behaviour of individual coronary arterial layer. In this 
model, the hyperelastic strain energy potential W is 
given by:[24]   
W = C10(I1 - 3) + (k1/2k2)[exp(k2<Ef>2) - 1] + (1/D)[(J2-1)/2 - lnJ]
Ef = k(I1 - 3) + (1 - 3k)(I4 - 1)
where C10, D, k1, k2 and k are model parameters, I1 
and J are the first and third stretch invariants, and I4 is 
the invariant of Cauchy-Green deformation tensor. The 
Macauley bracket is indicated by the operator <>, whilst 
γ represents the angle between the mean directions of 
the two families of fibres whose deformation is defined 
by Ef. The model parameters [Table 2] were calibrated 
against the experimental data.[25] Both longitudinal and 
circumferential stress-stretch responses, computed by 
using the HGO model, agreed with the experimental 
data very well[25] for all three vessel layers [Figure 4].
The HGO model used in this work is for incompressible 
hyperelastic materials. To consider compressible 
deformation, the HGO-C model was suggested, with 
the anisotropic part expressed by isochoric invariants 
Table 1: Properties for the Co-Cr L605 and Poly-L lactide 
stent materials[20,21]
Material ρ (kg/mm3) E (GPa) ν σy (MPa)
Co-Cr L605 9.1E-6 243 0.30 476
Poly-L lactide 1.4E-6 2.2 0.30 60
Table 2: Parameter values of the anisotropic Holzapfel-Gasser-Ogden model for the arterial layers
Layer ρ (kg/mm3) C10 D k1 k2 k γ
Intima 1.066E-6 0.03 8.95E-7 4.0 1200.0 0.303 60°
Media 1.066E-6 0.005 5.31E-6 0.57 80.0 0.313 20°
Adventitia 1.066E-6 8.32E-3 4.67E-6 1.0 1000.0 0.303 67°
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(insensitive to volumetric deformation). However, Nolan 
et al.[26] found that the HGO-C model was unable to 
simulate compressible anisotropic behavior correctly, 
because it used isochoric anisotropic invariants which 
is insensitive to volumetric deformation. Consequently, 
they formulated a modified anisotropic (MA) model by 
using the full anisotropic invariants which accounted 
for a volumetric anisotropic contribution. The MA 
model correctly predicted the material’s anisotropic 
response to hydrostatic tensile loading, pure shear 
and uniaxial deformations. They also found the HGO-C 
model significantly underpredicted arterial compliance, 
which might affect the simulation results of stent 
deployment in diseased arteries. To fully clarify this 
effect, a considerable amount of new work is required, 
especially the efforts required for coding a user-defined 
material subroutine for the MA model (interface with the 
FE package Abaqus). This is beyond the scope of this 
paper, and will be investigated in our future studies. 
Nevertheless, the HGO model used in this work 
was calibrated properly against the longitudinal and 
circumferential tensile data of arteries.[25] It was proved 
to be a reliable anisotropic formulation for modeling 
deformation of the arterial layers with collagen fibre 
reinforcement.
Crimping simulation
To model stent crimping, twelve rigid plates were 
generated around the stent as shown in Figure 5. The 
rigid plates were modelled as shell surfaces. Uniform 
radial displacement, linearly increasing to 1 mm within 
a step time of 0.1 s, was applied to the plates to enforce 
the crimping of stent. Spring back of the stent after 
crimping, due to the recovery of elastic deformation, 
resulted in a final stent diameter of 1.5 mm, which is 
able to fit in the diseased vessel.
Abaqus explicit was adopted for crimping simulations 
(0.1 s step time). No constraint was applied to the stent. 
Hard contact was assigned between the outer surface 
of the stent and the rigid plates. The friction coefficient 
was assumed to be 0.8. Following crimping, an 
additional step was used to simulate the spring back of 
the stent within 0.1 s. In this step, the contacts between 
the rigid plates and the stent were deleted, allowing for 
the stent to recover the elastic deformation freely.
Expansion simulation
The expansion procedure was simulated using two 
steps, namely inflation and deflation. During the 
inflation step (0.1 s), a pressure linearly increasing to 
1.2 MPa was applied inside the balloon. While in the 
deflation step (0.1 s), the balloon pressure was brought 
linearly down to zero. All analyses were carried out 
by considering the residual stresses generated from 
crimping. Again, simulations were performed using 
the explicit solver in Abaqus. Change of stent outer 
diameter was tracked for the middle ring and the two 
end rings of both stents. The data outputs were used 
to quantify stent expansion as well as the recoiling and 
dogboning effects.[27]
RESULTS
Stent crimping
During crimping, both stents underwent severe 
bending deformation, as illustrated in Figure 6 for Elixir 
stent. The two stents were squashed to a diameter of 
only 1.25 mm at the fully crimped state. After crimping, 
stresses were highly localised at the U-bend regions 
for both devices. The von Mises stress in the Xience 
and the Elixir stents had a maximum magnitude of 
750 MPa [Figure 7A right] and 96 MPa [Figure 7A 
left], respectively. After spring back, the maximum von 
Figure 1: Geometry and mesh for (A) Elixir and (B) Xience stents
Figure 2: Geometry and mesh of the artery with stenosis and 
angioplasty balloon
Figure 3: Stress-strain curves for the Co-Cr L605 alloy and Poly-L 
lactide[20,21]
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Mises stress in the Xience and Elixir stents relaxed to 
706 MPa and 50 MPa, respectively [Figure 7B]. These 
are also the residual stresses generated in the stent 
after crimping. And the diameter of both stents settled 
at about 1.5 mm.
Stent expansion
Pressure-diameter plots in Figure 8 showed that Elixir 
stent experienced a lower rate of expansion than 
Xience stent. Both stents developed a saturation state 
in expansion with the increasing pressure, but Elixir 
stent reached the saturation earlier. At the maximum 
pressure, the stent outer diameter was computed 
as 2.66 mm and 2.61 mm for the Xience and Elixir 
stents, respectively. The recoiling effect was 11% for 
the Xience stent [Figure 8B], which is significantly 
lower than that for the Elixir stent (20%; Figure 8B). 
Consequently, a larger final diameter was achieved 
for the Xience stent (2.40 mm) when compared to the 
Elixir stent (2.10 mm only). Consistently, the Xience 
stent also showed considerably less dogboning effect 
(24%) than the Elixir stent (45%).
High levels of stresses were developed in both stents 
following their deployment in the artery [Figure 9]. 
Similar to the crimping process, the maximum von 
Mises stresses were found in the U-bend districts, with 
a value of 935 MPa for the Xience and 95 MPa for 
the Elixir stent. In the artery, the peak stresses were 
generally found on the plaque, especially towards 
the ends of the stenosis. This was caused by the 
dogboning effect of the implanted stent. There is 
a direct connection between stress concentration 
and localized rupture for plaque as evidenced in 
numerous studies.[28,29] In our case, plaque rupture is 
likely to happen towards the ends of plaque region, a 
condition that can lead to heart attack (coronary artery) 
or stroke (carotid artery). In addition, there could be 
Figure 4: Stress-stretch curves for the three artery layers: Holzapfel-Gasser-Ogden model vs. experimental data[25]
Figure 5: Illustration of assembly used in crimping simulation for 
Elixir stent
Figure 6: Deformation of Elixir stent and balloon (A) before, (B) 
during and (C) at the end of the crimping process
                                                                                   Vessel Plus ¦ First Published on January 19, 2017
Schiavone et al.                                                                                                                                                           Modelling of metallic and polymeric stents
6
local damage to plaque/artery where the high stresses 
are located. This condition also leads to the growth of 
new tissue, e.g. proliferation of smooth muscle cells, 
around the stent, causing in-stent restenosis.
The maximum principal stress on the plaque had a peak 
value of 1.43 MPa and 0.54 MPa for the Xience and 
Elixir stents, respectively [Figure 10]. The considerably 
lower stress level for Elixir stent is consistent with 
the reduced property mismatch between the polymer 
and the artery as well as less arterial expansion 
achieved by the polymer stent. It should be noted that 
stress triaxiality was not explored for the stents and 
diseased artery. Stress triaxiality is defined as the 
ratio of hydrostatic stress to the equivalent (or von 
Mises) stress, and it is a key parameter used in ductile 
fracture analysis. In this study, we mainly focus on the 
stress state of stent-artery system during crimping and 
expansion, instead of fracture or failure. Consequently, 
stress triaxiality is not presented. But we aim to look into 
this in future studies when considering the failure and 
fracture of stent, plaque and arteries in the simulations.
Effect of residual stresses caused by crimping
As shown in Figure 7, crimping introduced severe 
residual stresses into the stent, which can affect the 
subsequent expansion of the device. To understand 
such effect, simulations of stent deployment were also 
carried out for both stents without including the residual 
stresses generated from crimping.
Figure 7: Von Mises stress (MPa) contour plot for the Elixir (left) and Xience (right) stents in (A) fully crimped state and (B) spring-back state
Figure 8: (A) Diameter change against pressure; (B) recoiling and 
dogboning effects during deployment of Elixir and Xience stents
Figure 9: Contour plot of the von Mises stress (MPa) on (A) Elixir 
and (B) Xience stents after deployment
Figure 10: Contour plot of maximum principal stress (MPa) on the 
stenotic plaque after stent deployment: (A) Elixir and (B) Xience 
stents
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For Elixir stent, it is confirmed that crimping-caused 
residual stresses do affect stent expansion [Figure 11]. 
When stent expansion was simulated without 
considering residual stress, the stent expanded faster 
and reached saturation earlier, as shown by the solid 
blue line in Figure 11A. Overall, residual stresses tend 
to compromise stent expansion both at peak pressure 
and after balloon deflation. At peak pressure, stent 
outer diameter was found to be 2.61 mm and 2.75 mm 
for simulations with and without considering residual 
stresses, respectively, and settled as 2.10 mm 
and 2.19 mm, respectively, after balloon deflation. 
Although the recoiling had similar magnitude for both 
cases (~20%; with and without residual stresses), 
less dogboning was found when residual stresses 
were excluded in simulations (i.e. 41%; versus 45% 
for simulations with residual stresses). As shown in 
Figure 12, residual stresses did not affect the pattern 
of stress distribution in the stent and artery. On the 
stent, stresses are still highly localised at the U-bend 
regions, regardless of the residual stress state. Also, 
the maximum stress on the stent changed only by 
~0.4% (95.69 to 95.32 MPa) when residual stresses 
were considered in the simulations. In the artery 
[Figure 12B], stresses were again concentrated 
towards the ends of the plaque as a result of stent 
dogboning effect. The peak value of the maximum 
principal stress changed by ~15% (0.64 to 0.54 MPa) 
when the residual stresses were included.
For Xience stent, residual stresses affected the early 
stage of expansion of the stent as shown in Figure 13. 
The achieved final diameter (~2.40 mm) and the recoiling 
effect (~11%) were similar for the two cases (with 
and without residual stresses). Dogboning increased 
when residual stresses were excluded, with a value 
of 36% (compared to 24% for the case considering 
residual stresses). As shown in Figure 14, the stresses 
developed in the stent and the diseased artery were 
similar, in terms of distribution, for the two cases (with 
and without residual stresses). In terms of magnitude, 
the maximum stress in the stent changed only by 
~0.7% (928.9 to 935.0 MPa) when residual stresses 
were included in the simulations. For the diseased 
artery, the peak value of the maximum principal stress 
changed by ~5% (1.50 MPa to 1.43 MPa) when the 
residual stresses were considered.
DISCUSSION
Clinically, in-stent restenosis (ISR), i.e. re-narrowing 
of stented artery, is one of the major drawbacks 
associated with stent implantation.[30] ISR is a direct 
consequence of the formation of neointima, largely 
caused by proliferating smooth muscle cells and 
accumulated extracellular matrix.[30] According to 
recent investigations, arterial wall biomechanics plays 
a key role in ISR. The stenting-caused alteration of 
biomechanical environment controls the inflammatory 
and remodelling processes of vessel walls. As reported 
by Timmins et al.,[31] stent designs that induced higher 
Figure 11: (A) Diameter change against pressure; and (B) recoiling 
and dogboning effects obtained from simulations with and without 
considering crimping-caused post-crimping stresses on Elixir stent
Figure 12: (A) von Mises stress (MPa) on the Elixir stent; and (B) maximum principal stress (MPa) on the artery-plaque system for 
simulations with (left) and without (right) considering residual stresses
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levels of non-physiologic stresses provoked a more 
aggressive pathobiological response of the vessel 
walls, leading to a higher degree of neointimal formation. 
In-vitro studies have also proved that mechanical 
stresses regulated the proliferation and migration of 
vascular cells,[32] and the synthesis and reorganization 
of extracellular matrix.[33] Stent-induced vessel stresses 
are closely linked with the level of artery injury, also 
promoting the development of restenosis. From this 
study, it is clear that the stresses in the artery appear to 
be largely affected by the stent materials and designs. 
PLLA has lower modulus, yield strength and strain 
hardening, which soothed the stent-artery interaction 
and led to stress reduction in vessel layers as shown 
in Figure 10. This is clinically beneficial. Bioresorbable 
polymeric stents are also more compliant than metallic 
stents, diminishing associated vascular responses 
over the scaffolded vessel segments.[34]
Residual stresses in stents were studied by Möller et al.[35] 
using X-ray diffraction method. Their work confirmed 
that even for as-produced stents, a significant amount 
of microstresses can be developed in the stent during 
crimping (this is also the case found in our work). 
Subsequent stent expansion caused an increase of 
stress due to tension. According to their study, the level 
of stresses introduced by crimping and expansion can 
considerably affect the fatigue life of the stent. Based 
on our results, crimping and expansion processes were 
found to induce comparable levels of stresses in the 
stent struts. Also, residual stresses developed during 
crimping affected the expansion behaviour, though 
only slightly, of stent in the deployment step. It is also 
thought that residual stresses in the stent contributed to 
the flexibility of the device, thus imposing less stresses 
on the plaque during further deformation as confirmed 
by our simulation results, although only marginally.
The targeted vessel diameter (i.e. 3 mm) could not 
be achieved by stent expansion only. This is the 
case for both polymer and metallic stents. Firstly, 
it was due to the saturated expansion of the artery 
layers, developed at a later stage of vessel stretching. 
This happened when the stiffness of vessel layers, 
especially the intima layer, increased steeply upon 
large stretch [Figure 4]. Secondly, vessel layers were 
assumed to deform purely elastically which imposed 
a large recovery force on the expanded stent after 
balloon deflation. Generally, the expansion of polymer 
stent was slower than that of metallic stent. Higher 
recoiling was also observed for polymeric stent due to 
the weaker mechanical properties. This indicates that 
there is a challenge to use polymer stents to achieve 
desired lumen diameter, especially for patients with 
stiffer artery and heavily calcified plaques. However, it 
is recognised that polymer stent induced significantly 
lower stresses in the artery than metallic stents, which 
could reduce the occurrence of arterial injuries and in-
stent restenosis.
In clinical practice, most stents are post-dilated with 
Figure 13: (A) Diameter change against pressure; and (B) recoiling 
and dogboning effects obtained from simulations with and without 
considering crimping-caused residual stresses on Xience stent
Figure 14: (A) von Mises stress on the Xience stent; and (B) maximum principal stress on the artery-plaque system for simulation with (left) 
and without (right) considering residual stresses
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relatively non-compliant balloons, i.e. stiffer and larger 
than the stent delivery system balloon, to ensure good 
apposition and to ensure that the intended diameter 
is achieved. However, multiple cycles of inflation were 
not simulated here which is a limitation of this study. 
The simulation in this work was a single deployment 
of stent or direct stenting of a vascular lesion. In 
clinical practice, pre-dilatation of diseased artery 
can also occur. Direct-stenting is common, but not 
with bioresorbable polymer stents. For bioresorbable 
polymer stents (or any new technology), the users 
generally acknowledge the importance of careful lesion 
preparation by pre-dilatation as well as post-dilatation. 
The pre-dilatation balloon inflation step modifies the 
plaque and results in less recoil after deployment 
of a stent or scaffold. After a stent is deployed, an 
additional post-dilatation generally occurs with a 
second larger balloon. Sometimes this is to achieve 
a better deployment through a tapered vessel, or to 
“crack” a stubborn plaque. Sometimes, this is required 
when two stents are deployed with an overlap. This 
type of balloon pre-dilatation and post-dilatation is 
essential for polymer stents to be effective in difficult 
lesions. In fact, larger degrees of recoil and dogboning 
predicted by the simulations indicate that adequate 
pre-dilatation and post-dilatation are potentially critical 
for polymeric stents to achieve optimal clinical results. 
Simulation of pre-dilation or post-dilation requires 
proper inelastic or damage models to describe 
unrecoverable deformation for the plaque and artery 
wall, which is currently beyond the scope of the paper. 
In this study, the artery and plaque were assumed to 
behave purely elastically (hyperelastic model), and the 
efforts of pre-dilation or post-dilation will be nullified as 
soon as the dilation pressure is removed. Modelling of 
inelastic deformation and damage will be attempted in 
our future work.
In addition, the stresses in the vessel layers at peak 
inflating pressure are generally beyond the ultimate 
tensile strength of the tissue layer.[25] This is also 
the case for the plaques. Therefore, tissue damage 
will need to be modelled in the FE simulations at 
high pressure levels. Tissue damage is associated 
with unrecoverable deformation in the artery, which 
could reduce the stent recoiling considerably upon 
balloon deflation. Consequently, stent is expected to 
expand further if tissue damage is considered due to 
irrecoverable mechanical deformation of the artery-
plaque system, thus resulting in a larger lumen diameter. 
Damage modeling of arterial layers is a limitation of this 
study and will be studied in our future work. However, 
it does not affect the general conclusion of this paper, 
as we aim to make like-for-like comparison of the 
scaffolding capability and mechanical performance 
between bioresorbable polymeric and metallic stents.
On the other hand, the plaque can be classified as 
hypocellular, cellular or calcified, depending on the 
composition. It is more difficult to treat calcified plaque 
by stenting due to its strong resistance to stretch when 
compared to hypocellular or cellular plaques.[18] So far, 
the effect of plaque composition on stent expansion was 
only evaluated for isotropic tissue model, and further 
work is required to study such effects by considering 
vessel anisotropy. Finally, polymers generally possess 
anisotropy and viscoplasticity effects which could 
also affect the simulation results and will need to be 
addressed in future studies.
In conclusion, crimping and deployment of polymeric 
and metallic stents have been simulated using finite 
element method to give a direct comparison of their 
mechanical performances. Results demonstrated 
that polymer stent has a lower rate of expansion than 
metallic stent. The overall expansion, reached at peak 
inflating pressure and after balloon deflation, was lower 
for polymer stent due to weaker material properties. 
This is also associated with the higher recoiling effect 
for polymer stent. Thus, it is a challenge to use polymer 
stent to treat patients with heavily calcified plaques or 
stiffer vessels, without pre-dilation or post-dilation. 
Crimping generated severe residual stresses in the 
stent, which tend to affect stent expansion and increase 
dogboning for Elixir polymer stent. However, they did 
not alter the stress distribution during the deployment 
process, and only imposed small changes to the stress 
magnitude.
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